In The Black Network Taps Brightcove to Power Its AVOD Streaming Platform
7.9.2023 15:58:00 EEST | Business Wire | Press release
Brightcove (NASDAQ: BCOV), the world’s most trusted streaming technology company, today announced it was selected by In The Black Network (ITBN) to power its AVOD streaming service expected to launch this October. ITBN is a new OTT venture founded and led by former FOX SOUL General Manager James DuBose. The new network focuses on streaming content that showcases and amplifies Black storytellers and culture.
ITBN will leverage Brightcove’s industry-leading technology to power its OTT service across all major connected TV devices and operating platforms. By partnering with Brightcove, ITBN will be able to deliver its content globally on demand with the best-in-class, highest quality, most scalable, and secure streaming technology platform. Additionally, ITBN will use Brightcove’s recently launched Ad Monetization service, designed to help companies maximize ad revenue opportunities.
“In The Black Network is gearing up to be the go-to streaming service for Black creators to share their voices across a wide range of audiences through compelling, impactful, original, and culturally relevant stories,” said Marc DeBevoise, CEO of Brightcove. “We’re thrilled to be a trusted partner for In The Black to help ensure they have the best technological capabilities to effortlessly deliver content at scale while boosting their ad revenue potential.”
“We found an ideal partner in Brightcove when searching for streaming technology that could help launch In The Black Network and evolve with us,” said In The Black Network’s Founder and CEO James DuBose. “They are the best in the industry, and we are proud to work closely with them.”
ITBN will stream an extensive collection of free entertainment content (including sports, music, scripted, drama, talk, family, and feature films) on a dedicated app available on iOS, Android devices, Apple TV, YouTube, ROKU, LG, Sony, and Samsung media players with more distribution partners to follow. The new streaming service joins a roster of media companies that rely on Brightcove to power their streaming capabilities, including AMC Networks, BBC Studios, Forbes, Rogers Media, Academy of Motion Picture Arts & Sciences, and Reelz.
For more information, visit Brightcove.com.
About In the Black Network
IN THE BLACK NETWORK (ITBN) is a AVOD streaming service that highlights Black voices and original stories that are culturally significant and relatable for all audiences. With an expansive collection of Black-focused entertainment, viewers can access multi-genre content from Black creators, including sports, music, scripted, drama, talk, family, feature films and more. The platform’s media library contains an extended list of fan-favorites from established studios and distributors, as well as a selection of content from the vault of Fox Television Stations: Brutally Honest with Jasmine Brand, CheMinistry, The Score, Worth a Conversation with Jeezy, Kitchen Talk with Maino, and Crockett’s Corner with Ray Crockett. In addition, ITBN produces original entertainment that further uplifts Black culture and pride. The premiere-free network streams on a dedicated app that is available for download on iOS, Android devices, Apple TV, YouTube ROKU, LG and Samsung media players.
About Brightcove, Inc.
Brightcove creates the world’s most reliable, scalable, and secure streaming technology solutions to build a greater connection between companies and their audiences, no matter where they are or on which devices they consume content. In more than 60 countries, Brightcove’s intelligent video platform enables businesses to sell to customers more effectively, media leaders to stream and monetize content more reliably, and every organization to communicate with team members more powerfully. With two Technology and Engineering Emmy® Awards for innovation, uptime that consistently leads the industry, and unmatched scalability, we continuously push the boundaries of what video can do. Follow on LinkedIn, Twitter, Facebook, Instagram and YouTube. Visit Brightcove.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230907446516/en/
Contact information
Media Contacts
Brightcove
Joseph J. Nuñez
jnunez@brightcove.com
In the Black Network
itbn@dkcnews.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release
PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release
Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release
Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release
Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
